Drug intelligence / Profile preview

nystatin oral suspension

Development stage
Phase 4
Lead developer
New York State Department of Health
Modality
Small Molecules
Administration
Oral
01

Overview

Mycostatin oral suspension is a brand-name formulation of nystatin, a polyene macrolide antifungal small molecule drug. Its active ingredient is nystatin, which is obtained from *Streptomyces noursei*. The drug works by binding to ergosterol in the fungal cell membrane, creating pores that cause leakage of intracellular contents (such as potassium ions), resulting in fungistatic or fungicidal effects. It is active against most pathogenic *Candida* species, including *Candida albicans*. The oral suspension is primarily indicated for the local treatment of oropharyngeal candidiasis (oral thrush) and related fungal infections of the mouth and gastrointestinal tract. Additionally, it is being investigated by National Taiwan University Hospital in a Phase 2 randomized trial as a perioperative gargle to reduce anastomotic leakage in patients undergoing esophagectomy for esophageal cancer.

Brand names
Bio-StatinMycostatinMycostatin oral suspensionNilstatNyadermNystex
Other names
fungicidinnystatinnystatin oral liquid
02

Targets

Ergosterol

Beyond the preview

Go deeper on nystatin oral suspension.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nystatin oral suspension.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call